The rising trend of on-demand and intermittent proton pump inhibitor therapy in gastroesophageal reflux disease: What is the evidence?

被引:1
作者
Bautista, Jimmy M.
机构
[1] Univ Santo Tomas Hosp, Gastroenterol Sect, Manila, Philippines
[2] Quirino Mem Med Ctr, Dept Med, Quezon City, Philippines
[3] Jose R Reyes Mem Med Ctr, Dept Surg, Manila, Philippines
关键词
D O I
10.1111/j.1440-1746.2006.04713.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Gastroesophageal reflux disease is a chronic and relapsing disease. Its symptoms do not correlate well with the degree of reflux events or injury that pose a challenge in its management. Thus far, treatment modalities include lifestyle and dietary modifications, antacids and anti-secretory medications, and anti-reflux surgery. With an erratic symptom atology, high cost of treatment, and fear of complications and side effects, the dilemma arises as to when treatment is stopped. Diverse therapeutic strategies continue to advance to address such concerns. The rising trend of on-demand and intermittent proton pump inhibitor therapy has raised various issues regarding efficacy.
引用
收藏
页码:S112 / S114
页数:3
相关论文
共 50 条
[21]   Dysphagia associated with gastroesophageal reflux disease is improved by proton pump inhibitor [J].
Oda, K ;
Iwakiri, R ;
Hara, M ;
Watanabe, K ;
Danjo, A ;
Shimoda, R ;
Kikkawa, A ;
Ootani, A ;
Sakata, H ;
Tsunada, S ;
Fujimoto, K .
DIGESTIVE DISEASES AND SCIENCES, 2005, 50 (10) :1921-1926
[22]   Dysphagia Associated with Gastroesophageal Reflux Disease Is Improved by Proton Pump Inhibitor [J].
Kayoko Oda ;
Ryuichi Iwakiri ;
Megumi Hara ;
Kazuyo Watanabe ;
Akiko Danjo ;
Ryo Shimoda ;
Atsushi Kikkawa ;
Akifumi Ootani ;
Hiroyuki Sakata ;
Seiji Tsunada ;
Kazuma Fujimoto .
Digestive Diseases and Sciences, 2005, 50 :1921-1926
[23]   Esophageal Mucosal Breaks in Gastroesophageal Reflux Disease Partially Responsive to Proton Pump Inhibitor Therapy [J].
Shaheen, Nicholas J. ;
Denison, Hans ;
Bjorck, Karin ;
Silberg, Debra G. .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 (04) :529-534
[24]   Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy [J].
Sugimoto, Mitsushige ;
Nishino, Masafumi ;
Kodaira, Chise ;
Yamade, Mihoko ;
Uotani, Takahiro ;
Ikuma, Mutsuhiro ;
Umemura, Kazuo ;
Furuta, Takahisa .
WORLD JOURNAL OF GASTROENTEROLOGY, 2011, 17 (14) :1858-1865
[25]   Characteristics of non-erosive gastroesophageal reflux disease refractory to proton pump inhibitor therapy [J].
Mitsushige Sugimoto ;
Masafumi Nishino ;
Chise Kodaira ;
Mihoko Yamade ;
Takahiro Uotani ;
Mutsuhiro Ikuma ;
Kazuo Umemura ;
Takahisa Furuta .
World Journal of Gastroenterology, 2011, 17 (14) :1858-1865
[26]   Economic evaluation of on-demand maintenance therapy with proton pump inhibitors in patients with symptomatic gastroesophageal reflux disease - A Monte-Carlo analysis for Italy [J].
Hughes, DA ;
Marchetti, M ;
Colombo, GL .
VALUE IN HEALTH, 2004, 7 (06) :753-754
[27]   Difference in efficacy of proton pump inhibitor between new-onset and recurrent gastroesophageal reflux disease: Result from a study of on-demand versus continuous maintenance therapy in Japan [J].
Nagahara, A. ;
Asaoka, D. ;
Hojo, M. ;
Sasaki, H. ;
Shimada, Y. ;
Matsumoto, K. ;
Ueyama, H. ;
Shibuya, T. ;
Sakamoto, N. ;
Osada, T. ;
Watanabe, S. .
HIPPOKRATIA, 2015, 19 (01) :53-56
[28]   What are the precautions with proton pump inhibitor use for reflux disease? [J].
Mospan, Cortney M. .
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2015, 28 (12) :23-26
[29]   The association between work productivity and response to proton pump inhibitor therapy in patients with gastroesophageal reflux disease [J].
Wahlqvist, P. ;
Ducrotte, P. ;
Jones, R. ;
Liker, H. .
VALUE IN HEALTH, 2006, 9 (06) :A247-A247
[30]   The efficacy and safety of itopride as an add-on therapy to a proton pump inhibitor in the treatment of gastroesophageal reflux disease [J].
Wasko-Czopnik, Dorota ;
Wiatrak, Benita .
GASTROENTEROLOGY REVIEW-PRZEGLAD GASTROENTEROLOGICZNY, 2024, 19 (01) :60-66